{"id":"NCT02585960","sponsor":"Baxalta now part of Shire","briefTitle":"BAX 855 PK-guided Dosing","officialTitle":"Phase 3, Prospective, Randomized, Multi-center Clinical Study Comparing the Safety and Efficacy of BAX 855 Following PK-guided Prophylaxis Targeting Two Different FVIII Trough Levels in Subjects With Severe Hemophilia A","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-11-23","primaryCompletion":"2018-08-05","completion":"2018-08-05","firstPosted":"2015-10-26","resultsPosted":"2019-08-26","lastUpdate":"2021-05-25"},"enrollment":135,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Hemophilia A"],"interventions":[{"type":"BIOLOGICAL","name":"PEGylated Recombinant Factor VIII","otherNames":["BAX855","BAX 855"]},{"type":"BIOLOGICAL","name":"PEGylated Recombinant Factor VIII","otherNames":["BAX 855","BAX855"]},{"type":"BIOLOGICAL","name":"PEGylated Recombinant Factor VIII","otherNames":["BAX855","BAX 855"]}],"arms":[{"label":"Pharmacokinetic (PK) evaluation of BAX 855","type":"EXPERIMENTAL"},{"label":"FVIII trough target 1-3%","type":"EXPERIMENTAL"},{"label":"FVIII trough target 8-12%","type":"EXPERIMENTAL"}],"summary":"1. To compare the efficacy and safety of pharmacokinetic (PK)-guided treatment with BAX 855 targeting FVIII trough levels of 1-3% and approximately 10% (8-12%)\n2. To further characterize pharmacokinetic (PK) and pharmacodynamic (PD) parameters of BAX 855","primaryOutcome":{"measure":"Percentage of Participants With a Total Annualized Bleeding Rate (ABR) of Zero for Second Six Months","timeFrame":"Day 183 to Day 364 (6 months)","effectByArm":[{"arm":"BAX 855-Low Level","deltaMin":42.1,"sd":null},{"arm":"BAX 855-High Level","deltaMin":62.1,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0545"}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":1},"locations":{"siteCount":83,"countries":["United States","Australia","Austria","Bulgaria","France","Germany","Hong Kong","Hungary","Israel","Italy","Malaysia","Norway","Poland","Romania","Singapore","Spain","Sweden","Switzerland","Taiwan","Turkey (TÃ¼rkiye)","Ukraine","United Kingdom"]},"refs":{"pmids":["37465396","36655343","33150384"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":57},"commonTop":["Upper respiratory tract infection","Arthralgia","Nasopharyngitis","Headache","Rhinitis"]}}